Literature DB >> 30506120

Relationship between thiol-disulphide homeostasis and visual evoked potentials in patients with multiple sclerosis.

Gönül Vural1, Şadiye Gümüşyayla2, Orhan Deniz2, Salim Neşelioğlu3, Özcan Erel3.   

Abstract

PURPOSE: To examine the thiol-disulphide homeostasis during an optic neuritis episode in patients with multiple sclerosis and the relationship between this homeostasis and P100 wave latency. MATERIALS AND
METHOD: Visual evoked potential reviews of multiple sclerosis patients who presented with an optic neuritis episode were conducted and P100 latencies were measured. Peripheral blood samples were collected from all patients. Native thiol and total thiol concentrations were measured with the automated method that was recently developed. Their amount of disulphide bonds, disulphide/native thiol, disulphide/total thiol and native thiol/total thiol ratios were calculated. The relationship between P100 latency and thiol-disulphide homeostasis was investigated.
RESULTS: A significant positive correlation was determined between the disulphide/native thiol ratio and both mean P100 latency and maximum P100 latency (p = 0.021, r = 0.136; p = 0.030, r = 0.177, respectively). DISCUSSION: As the balance of the plasma dominated by antioxidants moves towards the oxidant side, in other words as a higher rate of thiol is oxidised from the thiol pool, P100 latency is extended. N-acetylcysteine and alpha lipoic acid as well as thiol supplements can improve the thiol-disulphide balance, reinforce antioxidant defence and it can help in slowing down the demyelinating damage.

Entities:  

Keywords:  Multiple sclerosis; Optic neuritis; Oxidative stress; Thiol-disulphide homeostasis; Visual evoked potential

Mesh:

Substances:

Year:  2018        PMID: 30506120     DOI: 10.1007/s10072-018-3660-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  41 in total

1.  Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity.

Authors:  G Ferretti; T Bacchetti; F Principi; F Di Ludovico; B Viti; V A Angeleri; M Danni; L Provinciali
Journal:  Mult Scler       Date:  2005-12       Impact factor: 6.312

2.  Plasma lipid peroxidation and progression of disability in multiple sclerosis.

Authors:  M Koch; J Mostert; A V Arutjunyan; M Stepanov; A Teelken; D Heersema; J De Keyser
Journal:  Eur J Neurol       Date:  2007-05       Impact factor: 6.089

Review 3.  Evoked potentials for evaluation of multiple sclerosis.

Authors:  P Fuhr; L Kappos
Journal:  Clin Neurophysiol       Date:  2001-12       Impact factor: 3.708

4.  Redox modifications of protein-thiols: emerging roles in cell signaling.

Authors:  Saibal Biswas; Asiya Seema Chida; Irfan Rahman
Journal:  Biochem Pharmacol       Date:  2005-12-06       Impact factor: 5.858

5.  Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.

Authors:  Marcus Koch; Geeta S M Ramsaransing; Alexander V Arutjunyan; Michael Stepanov; Albert Teelken; Dorothea J Heersema; Jacques De Keyser
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

6.  Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis.

Authors:  Halit Tanju Besler; Selçuk Comoğlu; Zeki Okçu
Journal:  Nutr Neurosci       Date:  2002-06       Impact factor: 4.994

7.  Oxidative stress in patients with multiple sclerosis.

Authors:  C Syburra; S Passi
Journal:  Ukr Biokhim Zh (1999)       Date:  1999 May-Jun

8.  Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury.

Authors:  Mubeen A Ansari; Kelly N Roberts; Stephen W Scheff
Journal:  Free Radic Biol Med       Date:  2008-05-03       Impact factor: 7.376

Review 9.  Venom therapy in multiple sclerosis.

Authors:  Abbas Mirshafiey
Journal:  Neuropharmacology       Date:  2007-05-18       Impact factor: 5.250

10.  Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis.

Authors:  Halit Tanju Besler; Selçuk Comoğlu
Journal:  Nutr Neurosci       Date:  2003-06       Impact factor: 4.994

View more
  2 in total

Review 1.  Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Iphigenia Kanara; Anastasios N Mavrakis; Julie Pernokas; Mark Pernokas; Carl A Pinkert; Whitney R Powers; Konstantina Sampani; Kosta Steliou; Demetrios G Vavvas; Robert J Zamboni; Krishna Kodukula; Xiaohong Chen
Journal:  Biores Open Access       Date:  2020-03-31

2.  Investigating Different Forms of Hydrogen Sulfide in Cerebrospinal Fluid of Various Neurological Disorders.

Authors:  Viviana Greco; Cristina Neri; Damiana Pieragostino; Alida Spalloni; Silvia Persichilli; Matteo Gastaldi; Nicola B Mercuri; Patrizia Longone; Andrea Urbani
Journal:  Metabolites       Date:  2021-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.